Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Analyst Blog: Archive
Drug, Biotech Stocks' Q4 Earnings Due on Feb 6: AMGN, LLY & More
by Zacks Equity Research
Let's take a look at four biotech, drug companies, AMGN, LLY, GILD and EXEL, slated to release quarterly results on Feb 6.
LLYPositive Net Change AMGNNegative Net Change GILDNegative Net Change EXELNegative Net Change
biotechs medical
Medical Device Stocks' Earnings on Feb 1: RVTY, CAH & More
by Debanjana Dey
Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how CAH, RVTY, CNMD, SRDX and BDX are placed ahead of their earnings releases.
BDXNegative Net Change CNMDNegative Net Change CAHNegative Net Change SRDXNegative Net Change RVTYNegative Net Change
earnings medical medical-devices
Insurance Stocks' Q4 Earnings Due on Jan 31: AFL, MET & More
by Tanuka De
Better pricing, solid retention and renewals, exposure growth and accelerated digitalization are likely to drive fourth-quarter results of insurers like AFL, MET, AXS, SIGI and MTG.
MTGNegative Net Change METNegative Net Change AFLNegative Net Change AXSNegative Net Change SIGINegative Net Change
earnings insurance
Medical Products Q4 Earnings Due on Jan 31: BSX, TMO & ALGN
by Urmimala Biswas
Medical Products companies' fourth-quarter results are likely to reflect a year-over-year decline in earnings. Let's see how BSX, TMO and ALGN fare this time.
BSXNegative Net Change ALGNNegative Net Change TMONegative Net Change
earnings medical
Drug, Biotech Stocks' Q4 Earnings Due on Jan 31: NVO, NVS & GSK
by Ahan Chakraborty
Let's look at three biotech/drug companies, NVO, NVS and GSK, slated to release quarterly results on Jan 31.
GSKNegative Net Change NVSNegative Net Change JNJNegative Net Change NVOPositive Net Change
biotechnology biotechs medical pharmaceuticals
Medical Product Stocks' Q4 Earnings Due on Jan 30: SYK & More
by Indrajit Bandyopadhyay
Fourth-quarter results of Medical Product companies are likely to reflect a year-over-year improvement in revenues. Let's see how SYK, COR and ARAY fare this time around.
ARAYNegative Net Change SYKNegative Net Change CORPositive Net Change
medical medical-devices
3 Asset Management Stocks Set to Pull Off Earnings Beat in Q4
by Swayta Shah
Driven by solid market performance and moderate improvement in the operating backdrop, asset managers - SEI Investments (SEIC), T. Rowe Price (TROW) and Principal Financial (PFG) - are set to surpass estimates in Q4.
BLKNegative Net Change TROWNegative Net Change PFGNegative Net Change SEICNegative Net Change
earnings finance
Airline Stocks' Q4 Earnings Roster for Jan 25: AAL, ALK, LUV
by Zacks Equity Research
Investors interested in the Airline industry can watch out for fourth-quarter 2023 earnings reports of AAL, ALK and LUV, which are slated to release on Jan 25.
LUVNegative Net Change AALNegative Net Change ALKNegative Net Change
earnings transportation
Biotech/Drug Stocks Q3 Earnings Due Nov 7: GILD, PRGO, VTRS & More
by Zacks Equity Research
Let us take a look at what's in store for biotech/drug stocks GILD, PRGO, VTRS, SAGE and IOVA, which are scheduled to report on Nov 7.
BMYNegative Net Change GILDNegative Net Change PRGONegative Net Change SAGENegative Net Change IOVANegative Net Change VTRSNegative Net Change
biotechnology biotechs earnings medical pharmaceuticals
Energy Stocks' Q3 Earnings Roster for Nov 7: CIVI, DVN, WTI
by Nilanjan Banerjee
Favorable commodity prices likely to have aided the upstream business. Let's see how Civitas Resources (CIVI), Devon Energy (DVN) and W&T Offshore (WTI) are placed ahead of Q3 earnings.
DVNNegative Net Change WTINegative Net Change CIVINegative Net Change
oil-energy
Service Stocks' Nov 2 Earnings Roster: BR, APTV & PLTR
by Zacks Equity Research
Investors interested in the Business Services sector can watch out for earnings reports of BR, APTV and PLTR, to be released on Nov 2.
BRNegative Net Change APTVNegative Net Change PLTRNegative Net Change
business-services earnings
Medical Product Stocks' Q3 Earnings Due on Nov 1: SYK & More
by Indrajit Bandyopadhyay
Third-quarter results of Medical Product companies are likely to reflect a year-over-year decline. Let's see how SYK, COR, BAX, FMS and XRAY fare this time around.
BAXNegative Net Change SYKNegative Net Change XRAYNegative Net Change FMSNegative Net Change CORPositive Net Change
medical medical-devices
Utility Stocks Reporting Q3 Earnings on Nov 2: ED, DUK & More
by Tanvi Sarawagi
Let's focus on utilities like ED, DUK, EXC, PNW, LNT and NRG, which are scheduled to release third-quarter 2023 earnings on Nov 2.
EXCNegative Net Change NRGPositive Net Change DUKNegative Net Change EDNegative Net Change PNWNegative Net Change LNTNegative Net Change
utilities
MedTech Stocks' Q3 Earnings Due on Nov 1: IDXX, EXAS & More
by Urmimala Biswas
MedTech companies' third-quarter results are likely to reflect a year-over-year decline. Let's see how IDXX, EXAS, TNDM and NVST fare this time.
IDXXNegative Net Change EXASPositive Net Change TNDMNegative Net Change NVSTNegative Net Change
earnings medical
Insurance Stocks' Q3 Earnings Due on Nov 1: AFL, MET & More
by Zacks Equity Research
High interest rates and renewals favor insurers in Q3 but are partly offset by costs and CAT losses. AFL, MET, AIG, ALL & PRU will release earnings on Nov 1.
AIGNegative Net Change METNegative Net Change PRUNegative Net Change AFLNegative Net Change ALLNegative Net Change
earnings finance insurance
Utilities Due to Report Q3 Earnings on Nov 1: NI, ETR & More
by Jewel Saha
Let's focus on utilities like NI, ETR, AWK, DTE and EIX, scheduled to release their third-quarter earnings on Nov 1.
NINegative Net Change ETRNegative Net Change EIXNegative Net Change DTENegative Net Change AWKNegative Net Change
utilities
P&C Insurers to Post Q3 Earnings on Nov 1: SIGI, AXS & More
by Sushmita Sarker
Solid retention rates, continued rate increases and accelerated digitalization, partly offset by significant catastrophe losses, are likely to have influenced the third-quarter performances of SIGI, AXS, NMIH and AFG.
AXSNegative Net Change AFGNegative Net Change SIGINegative Net Change NMIHNegative Net Change
insurance
Solar Stocks to Watch for Earnings on Nov 1: RUN, SEDG & SPWR
by Aparajita Dutta
Earnings from the Oil-Energy sector, which houses all solar stocks, are expected to have declined 35.5% from the prior-year quarter's reported figure. Let's see how RUN, SEDG and SPWR report.
SPWRNegative Net Change ENPHNegative Net Change SEDGNegative Net Change RUNNegative Net Change
earnings oil-energy
Medical Device Stocks to Watch for Earnings on Nov 1: MCK & More
by Indrajit Bandyopadhyay
Medical Device companies' Q3 results are likely to reflect strength in customer demand. Let's see how MCK, QDEL, GKOS and NARI are placed ahead of their earnings release.
MCKPositive Net Change QDELNegative Net Change GKOSNegative Net Change NARINegative Net Change
medical medical-devices
Drug, Biotech Stocks' Q3 Earnings Due on Oct 31: AMGN, PFE, INCY
by Zacks Equity Research
Let's take a look at three biotech/drug companies, AMGN, PFE and INCY, slated to release quarterly results on Oct 31.
NVSNegative Net Change PFENegative Net Change AMGNNegative Net Change INCYNegative Net Change
biotechs pharmaceuticals
Utilities Due to Report Q3 Earnings on Oct 26: FE, PCG & More
by Jewel Saha
Let's focus on utilities like FE, PCG, CMS, XEL and CNP, which are scheduled to release third-quarter earnings on Oct 26.
XELNegative Net Change FENegative Net Change PCGNegative Net Change CMSNegative Net Change CNPNegative Net Change
utilities
MedTech Stocks to Watch for Earnings on Oct 26: WST, DXCM & More
by Debanjana Dey
MedTech companies' Q3 results are likely to reflect strength in customer demand. Let's see how WST, DXCM, MMSI and ITGR are placed ahead of their earnings releases.
DXCMNegative Net Change MMSINegative Net Change WSTNegative Net Change ITGRPositive Net Change
earnings medical medical-devices
Drug, Biotech Stocks' Q3 Earnings Due on Oct 26: BMY, MRK, BPMC
by Ahan Chakraborty
Let's look at three biotech/drug companies, BMY, MRK and BPMC, slated to release quarterly results on Oct 26.
BMYNegative Net Change JNJNegative Net Change MRKNegative Net Change BPMCNegative Net Change
biotechnology biotechs earnings medical pharmaceuticals
Medical Device Stocks' Q3 Earnings Due on Oct 26: BSX, BIO & More
by Urmimala Biswas
Medical Device companies' third-quarter results are likely to reflect a year-over-year decline. Let's see how BSX, BIO, EW and LH fare this time.
BSXNegative Net Change LHNegative Net Change EWNegative Net Change BIONegative Net Change
earnings medical
Auto Stocks' Q3 Earnings Lineup for Oct 26: F, HOG & More
by Rimmi Singhi
F, HOG, LKQ, OSK, and LEA are slated to release their Q3 results tomorrow. Our model anticipates an earnings beat for all companies except LKQ.
FPositive Net Change HOGNegative Net Change LEANegative Net Change OSKNegative Net Change LKQNegative Net Change
auto-tires-trucks earnings